Рекомбинантный рецепторный антагонист интерлейкина-1 человека - analogs
Components: Anakinra |
|||||||||
Pharmgroups: Hematopoiesis stimulants |
|||||||||
| Prices in pharmacies: — Instructions Рекомбинантный рецепторный антагонист интерлейкина-1 человека | |||||||||
|
ⓘXEnter drugs for checking interactions through a quick button search . Амибактам ✘ |
|
ⓘX diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
| Similar | Complete analog ⓘXAnalogues of the drug with completely identical active ingredients |
Prices in pharmacies |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘXAnalogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 68% — Барицитиниб Фармасинтез neutral [Baricitinib]
- 68% — Барицитиниб neutral [Baricitinib]
- 68% — Баритрона neutral [Baricitinib]
- 68% — Lefomide neutral [Leflunomide]
- 68% — Арресто neutral [Leflunomide]
- 68% 9.4-11€ Ehlafra neutral [Leflunomide]
- 68% 2.7-10€ Leflunomide Canon neutral [Leflunomide]
- 66% 18.9-19.6€ Leflaid Negative 🔍 [Leflunomide]
- 64% 4.5-6.5€ Arthrofon neutral
- 63% — Тофацитиниб Кроно neutral [Tofacitinib]
- 63% 350-446€ Jakvinus neutral [Tofacitinib]
- 63% — Тофацитиниба цитрат neutral [Tofacitinib]
- 63% — Relafen neutral [Nabumetone]
- 63% — Ацинатиб neutral [Tofacitinib]
- 63% — Тофацитиниб Дж neutral [Tofacitinib]
- 63% — Тофацитиниб-химрар neutral [Tofacitinib]
- 63% — Кселтицин neutral [Tofacitinib]
- 63% — Тофацитиниб-АМЕДАРТ neutral [Tofacitinib]
- 63% — Тофацитиниб Фармасинтез neutral [Tofacitinib]
- 61% 6.5-10€ Leflunomide Negative 🔍 [Leflunomide]
- 61% 4.1-13.1€ Arava Negative 🔍 [Leflunomide]
- 58% 4.7-8.5€ Пелубио neutral [Pelubiprofen]
- 57% 678.3-708.4€ Orensia neutral [Abatacept]
- 55% — Byanodine neutral [Penicillamine]
- 55% 43.4-62.4€ Cuprenyl neutral [Penicillamine]
- 55% — Пеницилламин-натив neutral [Penicillamine]
- 54% 649.6€ Kevzara neutral [Sarilumab]
- 54% 415€ Артлегиа neutral [Olokizumab]
- 52% — Tauredon Negative 🔍 [Sodium aurothiomalate]
- 46% 2.2€ Delagil neutral [Chloroquine]
- 46% 380-415€ Ранвэк neutral [Upadacitinib]
- 44% 240-490€ Simziya neutral [Certolizumab paegol]
- 44% 3.8-5.6€ Sulfasalazin Negative 🔍 [Sulfasalazine]
- 44% — Sulfasalazin-nativ Negative 🔍 [Sulfasalazine]
- 44% 6.4-10.2€ Hydroxychloroquine neutral [Hydroxychloroquine]
- 44% 1.5-7.8€ Aflubin neutral [Aconitum napellus and more 4Bryonia alba, Ferrum phosphoricum, Gentiana lutea, Sarcolacticum acidum]
- 44% 34€ Sulfasalazin-EN Negative 🔍 [Sulfasalazine]
- 43% 2.7-4.5€ Целекоксиб велфарм Dangerous 🔍 [Celecoxib]
- 43% — Ревмакокс Dangerous 🔍 [Celecoxib]
- 43% 4.5-14.7€ Целекоксиб-Тева Dangerous 🔍 [Celecoxib]
- 43% 4.1-8.3€ Флагзамма Dangerous 🔍 [Etoricoxib]
- 43% 3.1€ Остиоксиб Dangerous 🔍 [Etoricoxib]
- 43% — Эторикоксиб-АМ Dangerous 🔍 [Etoricoxib]
- 43% 1.9-3.6€ Эторикоксиб велфарм Dangerous 🔍 [Etoricoxib]
- 43% 1.8-7.7€ Целекоксиб Органика Dangerous 🔍 [Celecoxib]
- 42% 4.1-5.4€ Plaquenil neutral [Hydroxychloroquine]
- 40% — Nucleospermate sodium neutral [Nucleospermate sodium]
- 40% 4.4-9.9€ Nobedolak Dangerous 🔍 [Etodolac]
- 40% 3.2-4.9€ Meloxicam-SOLOpharm Dangerous 🔍 [Meloxicam]
- 40% 5.8€ Mesipol Dangerous 🔍 [Meloxicam]
Learn more about the selection of analogues
▶
- The drug has «Рекомбинантный рецепторный антагонист интерлейкина-1 человека» 1 full analog, the cheapest - Кинерет (199.5€); 51 analog by action, the most similar - Ehlafra (9.4-11€).
- Medical online service has selected the best substitutes for Рекомбинантный рецепторный антагонист интерлейкина-1 человека based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Рекомбинантный рецепторный антагонист интерлейкина-1 человека to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.